This federal Project Grant award of $678,809 from the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865, Child Health and Human Development Extramural Research, supports a randomized controlled trial to investigate aspirin pharmacokinetics and pharmacodynamics in high-risk singleton pregnancies. The objectives are to: 1) Determine platelet inhibition and factors impacting aspirin response at increased dosing through pregnancy; 2) Establish aspirin population pharmacokinetics and pharmacokinetic/pharmacodynamic relationships over gestation; and 3) Assess the association between aspirin response and perinatal outcomes. The research will be conducted by Thomas Jefferson University, doing business as Sidney Kimmel Medical College, a leading academic medical center, over the award period from January 13, 2025 to December 31, 2029.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $678.8k | 1/13/25 |